Allsup Cites New Study Tying Depression To Poorer Chemotherapy Outcomes In Lung Cancer Patients
January 23, 2017 09:30 ET | Allsup
BELLEVILLE, IL--(Marketwired - January 23, 2017) - A recent study of patients with lung cancer highlights the significance depression may have on treatment outcomes and the ability to work, according...
Elsevier Announces Updates to Two Key Virology Titles, Publication of Seven Additional Virology and Microbiology Books
December 06, 2016 04:00 ET | Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - December 06, 2016) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of the...
Guang Yue
Kessler Foundation Enrolling Participants for Breast Cancer Research Studies
October 24, 2016 16:37 ET | Kessler Foundation
EAST HANOVER, N.J., Oct. 24, 2016 (GLOBE NEWSWIRE) -- Kessler Foundation is recruiting study participants for research programs aimed at better understanding the long-term effects of breast cancer and...
Kessler Foundation logo
Kessler Foundation seeks participants for research studies
October 18, 2016 12:35 ET | Kessler Foundation
EAST HANOVER, N.J., Oct. 18, 2016 (GLOBE NEWSWIRE) -- Kessler Foundation is recruiting study participants for multiple research programs aimed at improving cognition, mobility, and long-term outcomes...
Home Infusion Therap
Home Infusion Therapy Market size worth $26.3 Billion by 2023: Global Market Insights Inc.
May 23, 2016 05:30 ET | Global Market Insights, Inc
Dover, DE, May 23, 2016 (GLOBE NEWSWIRE) -- Home Infusion Therapy Market size is projected to reach USD 26.3 billion by 2023; as per a new research report by Global Market Insights, Inc. Growing...
PharmaCyte Biotech C
PharmaCyte Biotech Clears Major Milestone on Path to FDA Clinical Trial
May 05, 2016 09:15 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - May 05, 2016) -  PharmaCyte Biotech (OTCQB: PMCB) has now reached a point in its life cycle where it is ready to start working with the U.S. FDA to get the company's...
Midatech Pharma anno
Midatech Pharma announces positive pharmacokinetic data with Q-Octreotide
April 26, 2016 02:00 ET | Midatech Pharma PLC
ABINGDON, England, April 26, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH; Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products in...
Midatech achieves po
Midatech achieves positive dosing data for OpsiSporin Uveitis programme
April 21, 2016 02:00 ET | Midatech Pharma PLC
ABINGDON, England, April 21, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
Midatech Pharma PLC 
Midatech Pharma PLC (“Midatech” or the “Company”) Audited financial results for the year ended 31 December 2015
April 13, 2016 02:00 ET | Midatech Pharma PLC
Midatech will host a conference call and live Q&A session today (Wednesday 13 April 2016) at 1300 BST / 0800 EDT for analysts and investors to discuss the Annual Results. Dr Jim Phillips, Chief...
Midatech’s Commercia
Midatech’s Commercial Launch of Zuplenz® (Ondansetron) Oral Soluble Film to Prevent Post-Operative, Chemotherapy and Radiation-Induced Nausea and Vomiting in US
April 11, 2016 02:00 ET | Midatech Pharma PLC
ABINGDON, England, April 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH); (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing...